Trial Profile
Repeat-Dose Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers.
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Cytisinicline (Primary)
- Indications Smoking withdrawal
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Achieve Life Sciences
- 22 Feb 2019 According to an Achieve Life Sciences media release,the company announced that the results for this study were presented on 22nd February 2019 at the Society for Research on Nicotine & Tobacco (SRNT) Annual Meeting in San Francisco
- 22 Feb 2019 Results of the final data published in the Achieve Life Sciences Media Release
- 05 Feb 2019 Status changed from recruiting to discontinued.